Author

C. M. Capelle

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell-cell communication· 1 Assay:flow cytometry· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

A. Cosma· 1 shared D. Latorre· 1 shared D. Lussi· 1 shared E. Masschelein· 1 shared F. Betsou· 1 shared F. Q. Hefeng· 1 shared G. Bernardini· 1 shared G. Turiel· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Cosma

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single cell compendium of muscle microenvironment in peripheral artery disease reveals altered endothelial diversity and LYVE1+ macrophage activation

G. Turiel, T. Desgeorges, E. Masschelein, Z. Fan, D. Lussi, C. M. Capelle, G. Bernardini, R. Ardicoglu, K. Schönberger, M. Birrer, S. F. Fucentese, J. Zhang, D. Latorre, S. Engelberger, K. De Bock

This study uses single-cell RNA sequencing and spatial transcriptomics to characterize the muscle microenvironment in PAD, identifying altered endothelial diversity and LYVE1+ macrophage activation.

bioRxiv · Jun 21, 2023Cell Biology

Standard PBMC cryopreservation selectively decreases detection of nine clinically-relevant T-cell markers

C. M. Capelle, S. Cire, W. Ammerlaan, M. Konstantinou, R. Balling, F. Betsou, A. Cosma, M. Ollert, F. Q. Hefeng

This study shows that standard PBMC cryopreservation reduces detection of nine T-cell markers but not others, highlighting potential issues in clinical trial interpretations.

bioRxiv · May 18, 2021Immunology